National Institutes of Health, National Cancer Institute, Division of Extramural Activities - Home Page
NIH NCI DEA Logo NIH NCI NCI/DEA
CTAC Meeting Presentations

Presentations from the 46th Meeting Held November 10, 2021

November 10
NIH Videocast
Call to Order & Opening Remarks
NCI Director's Update Dr. Sharpless
Legislative Update
Legislative Update Slides Ms. Holohan
Legislative Update Ms. Holohan
Clinician Scientist Awards Dr. Doroshow & Dr. Zahir
CTAC Strategic Planning Working Group Update Dr. Doroshow & Ms. Denicoff
FDA Draft Guidance on the Inclusion of Patient Reported Outcomes (PROs) in Cancer Clinical Trials
FDA Draft Guidance on PROs Dr. Bhatnagar & Dr. Kluetz
Inclusion of PROs in NCI Clinical Trials Dr. Minasian
The Value of and Challenges in Implementing PROs in Cancer Clinical Trials Dr. Dueck
Ongoing & New Business Dr. Meropol & Dr. Doroshow